Dopamine receptor inactivation in the caudate-putamen differentially affects the behavior of preweanling and adult rats

Neuroscience

Volumn 226, Issue , 2012, Pages 427-440

  Der Ghazarian, T ^a   Gutierrez, A ^a   Varela, F A ^a   Herbert, M S ^a   Amodeo, L R ^a   Charntikov, S ^a   Crawford, C A ^a   McDougall, S A ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Behavior; Caudate putamen; N ethoxycarbonyl 2 ethoxy 1,2 dihydroquinoline (EEDQ); Ontogeny; R( ) propylnorapomorphine (NPA)

Indexed keywords

2 ETHOXY 1(2H) QUINOLINECARBOXYLIC ACID ETHYL ESTER; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DIMETHYL SULFOXIDE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; PROPYLNORAPOMORPHINE; SULPIRIDE;

AGE; ALKYLATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CAUDATE NUCLEUS; CONTROLLED STUDY; FEMALE; HABITUATION; LOCOMOTION; MALE; MICROINJECTION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PUTAMEN; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RECEPTOR SENSITIVITY; STEREOTYPY;

AGING; ANIMALS; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; CAUDATE NUCLEUS; CONDITIONING, OPERANT; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; FEMALE; MALE; MICROINJECTIONS; MOTOR ACTIVITY; PUTAMEN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

EID: 84867625085     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.09.030     Document Type: Article

References (73)

1. Andersen S.L. Stimulants and the developing brain. Trends Pharmacol Sci 2005, 26:237-243.
2. Arnt J., Hyttel J. Postsynaptic dopamine agonistic effects of 3-PPP enantiomers revealed by bilateral 6-hydroxy-dopamine lesions and by chronic reserpine treatment in rats. J Neural Transm 1984, 60:205-223.
3. Arnt J., Hyttel J., Meier E. Inactivation of dopamine D-1 or D-2 receptors differentially inhibits stereotypies induced by dopamine agonists in rats. Eur J Pharmacol 1988, 155:37-47.
4. 2 dopamine agonists in intact rats. Brain Res 1989, 504:276-283.
5. Bordi F., Carr K.D., Meller E. Stereotypies elicited by injection of N-propylnorapomorphine into striatal subregions and nucleus accumbens. Brain Res 1989, 489:205-215.
6. Bowman B.P., Blatt B., Kuhn C.M. Ontogeny of the behavioral response to dopamine agonists after chronic cocaine. Psychopharmacology (Berl) 1997, 129:121-127.
7. 2 subtypes of dopamine receptors in rat brain. J Neurosci 1986, 6:3177-3188.
8. Cameron D.L., Crocker A.D. Alkylation of striatal dopamine receptors abolishes stereotyped behavior but has no effect on dopamine adenylate cyclase activity. Neurosci Lett 1988, 90:165-171.
9. Cameron D.L., Crocker A.D. Localization of striatal dopamine receptor function by central injection of an irreversible receptor antagonist. Neuroscience 1989, 32:769-778.
10. Cameron D.L., Crosbie J., Crocker A.D. A fixed interval momentary sampling method for assessing on-going behaviours induced by dopamine receptor agonists. Prog Neuropsychopharmacol Biol Psychiatry 1988, 12:595-606.
11. Campbell A., Baldessarini R.J. Effects of maturation and aging on behavioral responses to haloperidol in the rat. Psychopharmacology (Berl) 1981, 73:219-222.
12. Canales J.J., Iversen S.D. Behavioural topography in the striatum: differential effects of quinpirole and d-amphetamine microinjections. Eur J Pharmacol 1998, 362:111-119.
13. Carrera P.M., Brunhara F.C., Schwarting R.K., Tomaz C. Drug conditioning induced by intrastriatal apomorphine administration. Brain Res 1998, 790:60-66.
14. Charntikov S., Halladay L.R., Herbert M.S., Marquez E.M., McDougall S.A. Effects of dorsal striatal infusions of R(-)-propylnorapomorphine (NPA) on k-opioid-mediated locomotor activity in the young rat: possible role of the indirect pathway. Neuroscience 2008, 155:603-612.
15. Charntikov S., Der-Ghazarian T., Herbert M.S., Horn L.R., Widarma C.B., Gutierrez A., Varela F.A., McDougall S.A. Importance of D1 and D2 receptors in the dorsal caudate-putamen for the locomotor activity and stereotyped behaviors of preweanling rats. Neuroscience 2011, 183:121-133.
16. Cory-Slechta D.A., O'Mara D.J., Brockel B.J. Nucleus accumbens dopaminergic mediation of fixed interval schedule-controlled behavior and its modulation by low-level lead exposure. J Pharmacol Exp Ther 1998, 286:794-805.
17. Cory-Slechta D.A., Brockel B.J., O'Mara D.J. Lead exposure and dorsomedial striatum mediation of fixed interval schedule-controlled behavior. Neurotoxicology 2002, 23:313-327.
18. Crawford C.A., McDougall S.A., Rowlett J.K., Bardo M.T. Depletion of dopamine binding sites and dopamine levels and changes in dihydroxyphenylacetic acid levels in the 17- and 90-day-old rat striatum after irreversible receptor antagonism. Neurosci Lett 1992, 137:265-269.
19. 2 receptors after inactivation with EEDQ. Eur J Pharmacol 1994, 252:225-231.
20. Crawford C.A., Akopian G., Ring J., Jakowec M.W., Petzinger G.M., Andersen J.K., Vittozzi-Wong P., Wang K., Farley C.M., Charntikov S., Mitroi D., Beal M.F., Chow R., Walsh J.P. Acute and long-term response of dopamine nigrostriatal synapses to a single, low-dose episode of 3-nitropropionic acid-mediated chemical hypoxia. Synapse 2011, 65:339-350.
21. 2 receptor activation is critical but not the expression of the unconditioned response. Brain Res 2006, 1083:85-95.
22. Dickson P.R., Lang C.G., Hinton S.C., Kelley A.E. Oral stereotypy induced by amphetamine microinjection into striatum: an anatomical mapping study. Neuroscience 1994, 61:81-91.
23. 1 dopamine receptors on stereotypic and thermic responses to quinpirole (LY 171555). Neurosci Lett 1990, 115:81-85.
24. Farley C.M., Baella S.A., Wacan J.J., Crawford C.A., McDougall S.A. Pre- and postsynaptic actions of a partial D2 receptor agonist in reserpinized young rats: longevity of agonistic effects. Brain Res 2006, 1124:37-44.
25. Festa E.D., Russo S.J., Gazi F.M., Niyomchai T., Kemen L.M., Lin S.N., Foltz R., Jenab S., Quinones-Jenab V. Sex differences in cocaine-induced behavioral responses, pharmacokinetics, and monoamine levels. Neuropharmacology 2004, 46:672-687.
26. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 1992, 15:133-139.
27. Giorgi O., Biggio G. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists. Brain Res 1990, 533:53-59.
28. Giorgi O., Biggio G. Unilateral inactivation of dopamine receptors after intrastriatal injection of N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a novel rotational model to investigate dopamine receptor interactions. Pharmacol Biochem Behav 1990, 35:877-884.
29. Gnanalingham K.K., Hunter A.J., Jenner P., Marsden C.D. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat. Neuropharmacology 1994, 33:647-655.
30. Hamblin M.W., Creese I. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline. Life Sci 1983, 32:2247-2255.
31. Harrison L.M., LaHoste G.J. Rhes, the Ras homolog enriched in striatum, is reduced under conditions of dopamine supersensitivity. Neuroscience 2006, 137:483-492.
32. Hemsley K.M., Crocker A.D. Changes in muscle tone are regulated by D1 and D2 dopamine receptors in the ventral striatum and D1 receptors in the substantia nigra. Neuropsychopharmacology 2001, 25:514-526.
33. Hemsley K.M., Farrall E.J., Crocker A.D. Dopamine receptors in the subthalamic nucleus are involved in the regulation of muscle tone in the rat. Neurosci Lett 2002, 317:123-126.
34. Holson R.R., Pearce B. Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. Neurotoxicol Teratol 1992, 14:221-228.
35. Huynh H., Feldt L.S. Estimation of the Box correction for degrees of freedom from sample data in randomized block and split-plot designs. J Educ Stat 1976, 1:69-82.
36. Jaber M., Fournier M.C., Bloch B. Reserpine treatment stimulates enkephalin and D2 dopamine receptor gene expression in the rat striatum. Mol Brain Res 1992, 15:189-194.
37. Kelley A.E., Domesick V.B., Nauta W.J. The amygdalostriatal projection in the rat-an anatomical study by anterograde and retrograde tracing methods. Neuroscience 1982, 7:615-630.
38. 2A receptor binding and function in rat frontal cortex. Neuropharmacology 1999, 38:1421-1430.
39. Kreipke C.W., Walker P.D. NMDA receptor blockade attenuates locomotion elicited by intrastriatal dopamine D1-receptor stimulation. Synapse 2004, 53:28-35.
40. Krolewski D.M., Bishop C., Walker P.D. Intrastriatal dopamine D1 receptor agonist-mediated motor behavior is reduced by local neurokinin 1 receptor antagonism. Synapse 2005, 57:1-7.
41. Kula N.S., George T., Baldessarini R.J. Rate of recovery of D1 and D2 dopaminergic receptors in young vs. adult rat striatal tissue following alkylation with ethoxycarbonyl-ethoxy-dihydroquinoline (EEDQ). Dev Brain Res 1992, 66:286-289.
42. Lee C.Y., Double K.L., Crocker A.D. Expression of stereotyped behaviour requires stimulation of nigral D1 dopamine receptors. Brain Res 1995, 681:205-208.
43. Leff S.E., Gariano R., Creese I. Dopamine receptor turnover rates in rat striatum are age-dependent. Proc Natl Acad Sci USA 1984, 81:3910-3914.
44. Lepekhina L.M., Tsitsurina E.A. Stereotyped behavior in the ontogeny of rats. Bull Exp Biol Med 2007, 144:349-351.
45. McDougall S.A., Crawford C.A., Nonneman A.J. Effects of irreversible dopamine receptor inactivation on locomotor activity and grooming in the 17- and 90-day-old rat. Psychopharmacology (Berl) 1992, 106:502-510.
46. McDougall S.A., Crawford C.A., Nonneman A.J. Behavioral effects of selective and nonselective dopamine agonists on young rats after irreversible antagonism of D1 and/or D2 receptors. Psychopharmacology (Berl) 1993, 111:225-232.
47. McDougall S.A., Baella S.A., Stuebner N.M., Halladay L.M., Crawford C.A. Cocaine-induced behavioral sensitization in preweanling and adult rats: effects of a single drug-environment pairing. Psychopharmacology (Berl) 2007, 193:323-332.
48. Meller E., Enz A., Goldstein M. Absence of receptor reserve at striatal dopamine receptors regulating cholinergic neuronal activity. Eur J Pharmacol 1988, 155:151-154.
49. Meller E., Bordi F., Bohmaker K. Behavioral recovery after irreversible inactivation of D-1 and D-2 dopamine receptors. Life Sci 1989, 44:1019-1026.
50. Meller E., Bohmaker K., Goldstein M., Friedhoff A.J. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics. J Pharmacol Exp Ther 1985, 233:656-662.
51. Mestlin M., McDougall S.A. Ontogenetic differences in the effects of EEDQ on dopamine-mediated behaviors. Pharmacol Biochem Behav 1993, 45:797-802.
52. Milesi-Hallé A., McMillan D.E., Laurenzana E.M., Byrnes-Blake K.A., Owens S.M. Sex differences in (+)-amphetamine- and (+)-methamphetamine-induced behavioral response in male and female Sprague-Dawley rats. Pharmacol Biochem Behav 2007, 86:140-149.
53. A, receptor binding and function by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vitro and in vivo: effects of aging. J Neurochem 1991, 56:1241-1247.
54. Moody C.A., Spear L.P. Ontogenetic differences in the psychopharmacological responses to separate and combined stimulation of D1 and D2 dopamine receptors during the neonatal to weanling age period. Psychopharmacology 1992, 106:161-168.
55. Neisewander J.L., Ong A., McGonigle P. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ. Synapse 1995, 19:134-143.
56. Norman A.B., Eubanks J.H., Creese I. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain. J Pharmacol Exp Ther 1989, 248:1116-1122.
57. Paxinos G., Watson C. The rat brain: in stereotaxic coordinates 1998, Academic Press, San Diego. 4th ed.
58. 2-adrenoceptor binding sites in rat brain. Eur J Pharmacol 1998, 351:145-154.
59. Rosengarten H., Schweitzer J.W., Friedhoff A.J. A full repetitive jaw movement response after 70% depletion of caudate D1 receptors. Pharmacol Biochem Behav 1989, 34:895-897.
60. Rosengarten H., Schweitzer J.W., Friedhoff A.J. A subpopulation of dopamine D1 receptors mediate repetitive jaw movements in rats. Pharmacol Biochem Behav 1993, 45:921-924.
61. Sallés J., Wallace M.A., Fain J.N. Differential effects of alkylating agents on the multiple muscarinic receptor subtypes linked to activation of phospholipase C by carbachol in rat brain cortical membranes. J Pharmacol Exp Ther 1993, 264:521-529.
62. Schindler C.W., Carmona G.N. Effects of dopamine agonists and antagonists on locomotor activity in male and female rats. Pharmacol Biochem Behav 2002, 72:857-863.
63. High states, implying many paths to psychosis. Proc Natl Acad Sci USA 2005, 102:3513-3518.
64. Sherwood N.M., Timiras P. A stereotaxic atlas of the developing rat brain 1970, University of California Press, Berkeley.
65. Snyder K.J., Katovic N.M., Spear L.P. Longevity of the expression of behavioral sensitization to cocaine in preweanling rats. Pharmacol Biochem Behav 1998, 60:909-914.
66. Spear L.P. The use of psychopharmacological procedures to analyse the ontogeny of learning and retention: issues and concerns. Ontogeny of learning and memory 1979, 135-156. Lawrence Erlbaum Associates, Hillsdale, NJ. N.E. Spear, B.A. Campbell (Eds.).
67. Spear L.P., Brick J. Cocaine-induced behavior in the developing rat. Behav Neural Biol 1979, 26:401-415.
68. 1-adrenergic receptors. J Neurochem 1992, 59:331-337.
69. Van Hartesveldt C., Cottrell G.A., Potter T., Meyer M.E. Effects of intracerebral quinpirole on locomotion in rats. Eur J Pharmacol 1992, 214:27-32.
70. 1A receptors from N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) inactivation in regions of rat brain. Neurochem Res 2001, 26:113-120.
71. 2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia. J Pharmacol Exp Ther 2002, 300:850-861.
72. 3H]dopamine. Eur J Pharmacol 1988, 155:323-327.
73. Zorrilla E.P. Multiparous species present problems (and possibilities) to developmentalists. Dev Psychobiol 1997, 30:141-150.